xGene
xGene was founded in 2015 and has $20.0M in recorded funding across 1 round.
- Founded
- 2015
- Website
- xgenepharm.com
- Total Funding
- $20.0M
- Last Round
- $20.0M Series BOct 2018
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
Xgene Pharmaceutical Inc. engineers high-impact medications for unmet underserved needs in neurological conditions. Xgene's proprietary linker technology generates novel dual-acting conjugates combining two well-characterized and efficacious therapeutic molecules to produce a targeted multimodal approach.
Summary
xGene is a Biotech company, founded in 2015. It has raised $20.0M in total across 1 round, most recently a $20.0M Series B round in Oct 2018. Investors include Ping An Capital.
Funding History
Oct 2018
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/xgene"><img src="https://indexed.vc/api/badge/company/xgene" alt="xGene on Indexed.vc" width="260" height="76" /></a>